SHARE
 
Paul M. Harari, MD close
9hHc9jBi3UE
Paul M. Harari, MD
 

New Patients

Contact the Welcome Center for help choosing a new primary care doctor.

For Referring Physicians

How to refer a patient

Paul M. Harari, MD Print Friendly Page

Chair, Department of Human Oncology
Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Harari’s medical interests include radiation oncology, head and neck oncology, and oncology training and education.

Specialties

Clinics

UW Carbone Cancer Center
(608) 263-8500 | (800) 323-8942 | Map
UW Carbone Cancer Center
(608) 265-1700 | (800) 323-8942 | Map

UW School of Medicine and Public Health

Department of Human Oncology

Professional Certifications and Education

Board Certification Radiation Oncology
Residency The University of Arizona Medical Center, Tuscon, AZ
Internship University of California-Davis Medical Center, Sacramento, CA
Medical School University of Virginia School of Medicine, Charlottesville, VA

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
Research

Dr. Harari's clinical and laboratory research focuses on treatment advances for head and neck cancer patients through precision radiation techniques and the use of molecular targeted growth inhibitors combined with radiation.


PubMed Articles
Gong MM Lugo-Cintron KM White BR Kerr SC Harari PM Beebe DJ Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function. Biomaterials . 2019 Sep;214:119225
[PubMed ID: 31154151]
Harari PM Open the Gates for Treatment De-Intensification in Head and Neck Cancer. J Clin Oncol . 2019 Aug 1;37(22):1854-1855
[PubMed ID: 31194612]
Thompson JD Avey GD Wieland AM Harari PM Glazer TA McCulloch TM Hartig GK Auriculotemporal Nerve Involvement in Parotid Bed Malignancy. Ann Otol Rhinol Laryngol . 2019 Jul;128(7):647-653
[PubMed ID: 30894024]
Burr AR Harari PM Ko HC Bruce JY Kimple RJ Witek ME Reducing radiotherapy target volume expansion for patients with HPV-associated oropharyngeal cancer. Oral Oncol . 2019 May;92:52-56
[PubMed ID: 31010623]
Bowen RC Ko HC Avey GD Hartig GK Hu R Harari PM Lucarelli MJ Personalized Treatment for Lacrimal Sac Adenoid Cystic Carcinoma: Case Report and Literature Review. Pract Radiat Oncol . 2019 May;9(3):136-141
[PubMed ID: 30731273]
Gillison ML Trotti AM Harris J Eisbruch A Harari PM Adelstein DJ Sturgis EM Burtness B Ridge JA Ringash J Galvin J Yao M Koyfman SA Blakaj DM Razaq MA Colevas AD Beitler JJ Jones CU Dunlap NE Seaward SA Spencer S Galloway TJ Phan J Dignam JJ Le QT Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet . 2019 Jan 5;393(10166):40-50
[PubMed ID: 30449625]
Zhang QE Wu Q Harari PM Rosenthal DI Randomized phase II/III confirmatory treatment selection design with a change of survival end points: Statistical design of Radiation Therapy Oncology Group 1216. Head Neck . 2019 Jan;41(1):37-45
[PubMed ID: 30549358]
Gay HA Santiago R Gil B Remedios C Montes PJ López-Araujo J Chévere CM Imbert WS White J Arthur DW Horton JK Jagsi R Rabinovich R Beriwal S Viswanathan A Erickson BA Rengan R Palma D Loo BW Jr Kavanaugh JA Bradley J Yom SS Harari PM Lee Burnett O 3rd Lessons Learned From Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients. Pract Radiat Oncol . 2019 Sep - Oct;9(5):305-321
[PubMed ID: 30999000]
Elsaid MY Shahi A Wang AR Baiu DC Li C Werner LR Singhal S Hall LT Weichert JP Armstrong EA Bednarz BP Harari PM Iyer G Otto M Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog. Mol Cancer Ther . 2018 Nov;17(11):2320-2328
[PubMed ID: 30108133]
McDaniel NK Cummings CT Iida M Hülse J Pearson HE Vasileiadi E Parker RE Orbuch RA Ondracek OJ Welke NB Kang GH Davies KD Wang X Frye SV Earp HS Harari PM Kimple RJ DeRyckere D Graham DK Wheeler DL MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents. Mol Cancer Ther . 2018 Nov;17(11):2297-2308
[PubMed ID: 30093568]
Thompson JD Harari PM Hartig GK Is HPV-Associated Oropharyngeal Cancer Becoming More Common in Older Patients? Laryngoscope Investig Otolaryngol . 2018 Dec;3(6):446-449
[PubMed ID: 30599028]
Blitzer GC Rosenberg SA Anderson BM McCulloch TM Wieland AM Hartig GK Bruce JY Witek ME Kimple RJ Harari PM Results From 10 Years of a Free Oral Cancer Screening Clinic at a Major Academic Health Center. Int J Radiat Oncol Biol Phys . 2018 Sep 1;102(1):146-148
[PubMed ID: 29980415]
Davidson SM Ko HC Harari PM Wieland AM Chen S Baschnagel AM Kimple RJ Witek ME Impact of HPV Status on the Prognostic Potential of the AJCC Staging System for Larynx Cancer. Otolaryngol Head Neck Surg . 2018 Sep;159(3):456-465
[PubMed ID: 29611770]
Rosenberg SA Henke LE Shaverdian N Mittauer K Wojcieszynski AP Hullett CR Kamrava M Lamb J Cao M Green OL Kashani R Paliwal B Bayouth J Harari PM Olsen JR Lee P Parikh PJ Bassetti M A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy. Adv Radiat Oncol . 2019 Jan-Mar;4(1):142-149
[PubMed ID: 30706022]
Morris ZS Guy EI Werner LR Carlson PM Heinze CM Kler JS Busche SM Jaquish AA Sriramaneni RN Carmichael LL Loibner H Gillies SD Korman AJ Erbe AK Hank JA Rakhmilevich AL Harari PM Sondel PM Tumor-Specific Inhibition of <i>In Situ</i> Vaccination by Distant Untreated Tumor Sites. Cancer Immunol Res . 2018 Jul;6(7):825-834
[PubMed ID: 29748391]
Witek ME Hartig GK Harari PM Survival Outcomes for Patients With T3N0M0 Squamous Cell Carcinoma of the Glottic Larynx-Reply. JAMA Otolaryngol Head Neck Surg . 2018 Jun 1;144(6):543
[PubMed ID: 29621382]
Bristow RG Alexander B Baumann M Bratman SV Brown JM Camphausen K Choyke P Citrin D Contessa JN Dicker A Kirsch DG Krause M Le QT Milosevic M Morris ZS Sarkaria JN Sondel PM Tran PT Wilson GD Willers H Wong RKS Harari PM Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. Lancet Oncol . 2018 May;19(5):e240-e251
[PubMed ID: 29726389]
Mittauer K Paliwal B Hill P Bayouth JE Geurts MW Baschnagel AM Bradley KA Harari PM Rosenberg S Brower JV Wojcieszynski AP Hullett C Bayliss RA Labby ZE Bassetti MF A New Era of Image Guidance with Magnetic Resonance-guided Radiation Therapy for Abdominal and Thoracic Malignancies. Cureus . 2018 Apr 4;10(4):e2422
[PubMed ID: 29872602]
Yom SS Harari PM When Disaster Strikes: Mitigating the Adverse Impact on Head and Neck Cancer Patients. Int J Radiat Oncol Biol Phys . 2018 Mar 15;100(4):838-840
[PubMed ID: 29485057]
Burr AR Harari PM Ko HC Chen S Yu M Baschnagel AM Kimple RJ Witek ME HPV impacts survival of stage IVC non-oropharyngeal HNSCC cancer patients. Otorhinolaryngol Head Neck Surg . 2018;3(1)
[PubMed ID: 30271885]